Dong Hyun Sinn

Assistant Professor

Samsung Medical Center

South Korea

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

100%

Clinical Nutrition

60%

Liver Fibrosis

90%

Fatty Liver

70%

Hepatobiliary Surgery

50%

Liver Transplantation

40%

Liquid Biopsy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles16

Exploring the role of liver resection as a first-line treatment option for multinodular BCLC-A hepatocellular carcinoma

Article Link

Year:

2024

Analysis of Factors Predicting the Real-World Efficacy of Atezolizumab and Bevacizumab in Patients with Advanced Hepatocellular Carcinoma

Article Link

Year:

2024

Role of transarterial chemoembolization for hepatocellular carcinoma with extrahepatic metastases in the era of advancing systemic therapy

Article Link

Year:

2024

Multidisciplinary approach for hepatocellular carcinoma patients: current evidence and future perspectives

Article Link

Year:

2024

A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization

Article Link

Year:

2023

Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis

Article Link

Year:

2023

Validation of non‐invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII

Article Link

Year:

2023

Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study

Article Link

Year:

2023

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Article Link

Year:

2023

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Article Link

Year:

2023

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Article Link

Year:

2023

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Article Link

Year:

2023

Associations of physical activity domains and muscle strength exercise with non-alcoholic fatty liver disease: a nation-wide cohort study

Article Link

Year:

2023

Letter: comment on Park et al – the association of non‐alcoholic fatty liver disease between parents and adolescent children – authors' reply

Article Link

Year:

2023

Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B

Article Link

Year:

2023

Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation

Article Link

Year:

2023

Collaborators10

Jung Hee Kim

Assistant professor

Hallym University Dongtan Sacred Heart Hospital

SOUTH KOREA

Young-Suk Lim

Professor

University of Ulsan College of Medicine

SOUTH KOREA

Young Seok Kim

Soonchunhyang University Hospital Bucheon

SOUTH KOREA

Won Hyuk Chang

Associate Professor

Samsung Medical Center

SOUTH KOREA

Seung-Woon Paik

Sungkyunkwan University School of Medicine

SOUTH KOREA

Won Sohn

Sungkyunkwan University School of Medicine

SOUTH KOREA

Kyunga Kim

Associate Professor

Samsung Medical Center

SOUTH KOREA

Geum‐Youn Gwak

SOUTH KOREA

Wonseok Kang

Sungkyunkwan University School of Medicine

SOUTH KOREA

Jihye Kim

Clinical professor

Seoul National University Hospital

SOUTH KOREA

How do I reach out?

Meet Kite AI